Atıf Formatları
A DcR2 siRNA approach overcomes TRAIL resistance in A549 lung cancer cells
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

S. ŞANLIOĞLU Et Al. , "A DcR2 siRNA approach overcomes TRAIL resistance in A549 lung cancer cells," 13th Annual Congress of European Society of Gene Therapy , Prague, Czech Republic, pp.172, 2005

ŞANLIOĞLU, S. Et Al. 2005. A DcR2 siRNA approach overcomes TRAIL resistance in A549 lung cancer cells. 13th Annual Congress of European Society of Gene Therapy , (Prague, Czech Republic), 172.

ŞANLIOĞLU, S., ŞANLIOĞLU, A. D., aydın, ç., DERTSİZ, L., & ÖZBUDAK, Ö., (2005). A DcR2 siRNA approach overcomes TRAIL resistance in A549 lung cancer cells . 13th Annual Congress of European Society of Gene Therapy (pp.172). Prague, Czech Republic

ŞANLIOĞLU, SALİH Et Al. "A DcR2 siRNA approach overcomes TRAIL resistance in A549 lung cancer cells," 13th Annual Congress of European Society of Gene Therapy, Prague, Czech Republic, 2005

ŞANLIOĞLU, SALİH Et Al. "A DcR2 siRNA approach overcomes TRAIL resistance in A549 lung cancer cells." 13th Annual Congress of European Society of Gene Therapy , Prague, Czech Republic, pp.172, 2005

ŞANLIOĞLU, S. Et Al. (2005) . "A DcR2 siRNA approach overcomes TRAIL resistance in A549 lung cancer cells." 13th Annual Congress of European Society of Gene Therapy , Prague, Czech Republic, p.172.

@conferencepaper{conferencepaper, author={SALİH ŞANLIOĞLU Et Al. }, title={A DcR2 siRNA approach overcomes TRAIL resistance in A549 lung cancer cells}, congress name={13th Annual Congress of European Society of Gene Therapy}, city={Prague}, country={Czech Republic}, year={2005}, pages={172} }